Inhibition of ceramide generation protected mice from cisplatin-induced AKI, while inhibition of glucosylceramide synthase, an enzyme that glycosylates ceramide species to generate glycosphingolipids, exacerbated cisplatin-induced AKI (21). This evidence concerns the gene UGCG and acute kidney injury.